The analysis revealed that the DDX5 mRNA increase in tumors is related to decreased overall survival (OS), progression-free interval (PFI), and disease-specific survival (DSS) in 3 cancers but increased OS, PFI, and DSS in others [111]. This evidence concerns the gene DDX5 and cancer.